ArticleCancers2025

Maintenance Treatment with 5-Azacitidine in Patients with Acute Myeloblastic Leukemia Ineligible for Intensive Treatment and with Response After Induction Chemotherapy: A Phase II Clinical Trial.

Alfonso Fernández Fernández et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.